Treatments for opioid use disorder among pregnant and reproductive-aged women

Fertil Steril. 2017 Aug;108(2):222-227. doi: 10.1016/j.fertnstert.2017.06.011. Epub 2017 Jul 8.

Abstract

The increased prevalence of opioid use disorder and access to medical insurance is subsequently increasing the likelihood that medical professionals will encounter individuals with opioid use disorder. Sharp increases in opioid use disorder among women mean that obstetricians, gynecologists, and other reproductive medicine providers may be especially likely to encounter such patients. Medical professionals' understanding of treatment for opioid use disorder and their roles in their patients' treatment may increase referrals to treatment, reduce stigma, and improve the quality of medical care. Treatment for opioid use disorder falls into four overlapping domains: medication management, medical care, behavioral/mental health care, and psychosocial support. In this review, we discuss these domains with an emphasis on pregnant women and women of reproductive age. Treatment for opioid use disorder is most effective when all providers coordinate care in an informed, nonjudgmental, patient-centered approach.

Keywords: Buprenorphine; medication-assisted treatment; methadone; opioid; substance use disorder.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Cognitive Behavioral Therapy / methods*
  • Combined Modality Therapy / methods
  • Evidence-Based Medicine
  • Female
  • Humans
  • Middle Aged
  • Narcotic Antagonists / administration & dosage*
  • Opiate Substitution Treatment / methods*
  • Opioid-Related Disorders / diagnosis
  • Opioid-Related Disorders / psychology
  • Opioid-Related Disorders / therapy*
  • Pregnancy
  • Pregnancy Complications / diagnosis
  • Pregnancy Complications / psychology
  • Pregnancy Complications / therapy*
  • Treatment Outcome
  • Women's Health*
  • Young Adult

Substances

  • Narcotic Antagonists